<!-- SEGMENTS v2025-08-12d -->
<style>
.table-wrap{overflow:auto; max-width:100%;}
.segment-pivot{width:100%;border-collapse:collapse;font-family:Arial,sans-serif;font-size:14px}
.segment-pivot thead th{position:sticky;top:0;background:#fff;z-index:1;border-bottom:1px solid #ddd}
.segment-pivot th,.segment-pivot td{padding:6px 8px;border-bottom:1px solid #f0f0f0}
.segment-pivot tbody tr:nth-child(even){background:#fafafa}
.segment-pivot td,.segment-pivot th{white-space:nowrap}
.segment-pivot td{font-variant-numeric:tabular-nums;text-align:right}
.segment-pivot td:first-child,.segment-pivot th:first-child{text-align:left}
.table-note{font-size:12px;color:#666;margin:6px 0 8px}
</style>
<div class="table-note">SEGMENTS v2025-08-12d · 2025-08-17 07:25 UTC — Each section uses a single scale. TTM is <b>bold</b>. “% of Total (TTM)” uses the visible rows in that section.</div>
<h3 style='margin:10px 0 6px'>Products / Categories</h3>
<div class='table-wrap'><table class="dataframe segment-pivot">
  <thead>
    <tr style="text-align: right;">
      <th>Segment</th>
      <th>2023 Rev ($B)</th>
      <th>2023 OI ($B)</th>
      <th>2024 Rev ($B)</th>
      <th>2024 OI ($B)</th>
      <th>TTM Rev ($B)</th>
      <th>TTM OI ($B)</th>
      <th>% of Total (TTM)</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Pharmaceutical</td>
      <td>0.82B</td>
      <td>0.00B</td>
      <td>1.10B</td>
      <td>0.00B</td>
      <td><strong>1.10B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>100.0%</td>
    </tr>
  </tbody>
</table></div>

<hr/>
<h3 style='margin:10px 0 6px'>Other / Unclassified</h3>
<div class='table-wrap'><table class="dataframe segment-pivot">
  <thead>
    <tr style="text-align: right;">
      <th>Segment</th>
      <th>2023 Rev ($B)</th>
      <th>2023 OI ($B)</th>
      <th>2024 Rev ($B)</th>
      <th>2024 OI ($B)</th>
      <th>TTM Rev ($B)</th>
      <th>TTM OI ($B)</th>
      <th>% of Total (TTM)</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Innovative Medicine</td>
      <td>750B</td>
      <td>0.00B</td>
      <td>398B</td>
      <td>0.00B</td>
      <td><strong>575B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>52.0%</td>
    </tr>
    <tr>
      <td>Med Tech</td>
      <td>405B</td>
      <td>0.00B</td>
      <td>223B</td>
      <td>0.00B</td>
      <td><strong>330B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>29.8%</td>
    </tr>
    <tr>
      <td>Oncology</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>54.9B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>5.0%</td>
    </tr>
    <tr>
      <td>Immunology</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>35.1B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>3.2%</td>
    </tr>
    <tr>
      <td>Surgery</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>22.5B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>2.0%</td>
    </tr>
    <tr>
      <td>Orthopaedics</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>20.6B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>1.9%</td>
    </tr>
    <tr>
      <td>Neuroscience</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>17.2B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>1.6%</td>
    </tr>
    <tr>
      <td>Vision</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>12.1B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>1.1%</td>
    </tr>
    <tr>
      <td>Pulmonary Hypertension</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>9.76B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>0.9%</td>
    </tr>
    <tr>
      <td>Cardiovascular Metabolism Other</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>8.62B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>0.8%</td>
    </tr>
    <tr>
      <td>Infectious Diseases</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>7.23B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>0.7%</td>
    </tr>
    <tr>
      <td>Cardiovascular</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>6.73B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>0.6%</td>
    </tr>
    <tr>
      <td>Electrophysiology</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>4.26B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>0.4%</td>
    </tr>
    <tr>
      <td>Abiomed</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>1.32B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>0.1%</td>
    </tr>
    <tr>
      <td>Shockwave</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.84B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>0.1%</td>
    </tr>
    <tr>
      <td>Other Cardiovascular</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.31B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>0.0%</td>
    </tr>
  </tbody>
</table></div>
